About Braveheart Bio, Inc. (BRVE) data
Data as of September 30, 2026.
Braveheart Bio, Inc. (BRVE) has 4.13M shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 67.77% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 5.10 days (days to cover).
Frequently asked questions
What is the current short interest in BRVE?
As of the latest FINRA settlement dated September 30, 2026, BRVE had approximately 4,128,974 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short BRVE?
The latest borrow fee (cost to borrow) for BRVE is 9.75% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for BRVE?
Days to cover for BRVE is approximately 5.10 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
How many BRVE shares failed to deliver?
On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 3,070 shares of BRVE had failed to deliver, worth about $68.58K at the prior day's close (under 0.01% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.
Is BRVE a short squeeze candidate?
A squeeze needs shorts that are hard to close. BRVE trades about 809,950 shares a day and would take roughly 5.10 days to unwind current short positions, at a current borrow fee of 9.75%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.